Alliance Pharma Stock Forecast for 2023 - 2025 - 2030

Updated on 03/27/2024

Stock Rating
18
Price Target
£0.60
Consensus
Outperform
Upside
53.85%
Analysts
2
Stock Rating
18
Upside
53.85%
Analysts
2
Price Target
£0.60

Alliance Pharma Stock Forecast and Price Target

The average price target for Alliance Pharma's stock of £0.60 recently provided by two leading analysts would represent a 53.85% upside from its last closing price if reached. This potential increase is based on a high estimate of £1.00 and a low estimate of £0.42. Even if you are not interested in APH stock, it is still imperative to be aware of its competitors.

£0.60

53.85% Upside

Outperform
Outperform

Alliance Pharma Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Alliance Pharma's Price has gone down from £0.81 to £0.00 – a 100.00% drop. The next year looks promising for Alliance Pharma, with analysts predicting Fair Value of £0.81 – an increase of 100.00%. Over the next seven years, experts anticipate that Alliance Pharma's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
£0.81
2025 Fair Value Forecast
£0.97
2026 Fair Value Forecast
£1.13
2027 Fair Value Forecast
£1.29
2028 Fair Value Forecast
£1.10
2029 Fair Value Forecast
£1.07
2030 Fair Value Forecast
£1.10

Alliance Pharma Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Alliance Pharma's Revenue has grown, increasing from £129.80M to £167.42M – a growth of 28.98%. The next year looks promising for Alliance Pharma, with analysts predicting Revenue of £198.87M – an increase of 18.79%. Over the next seven years, experts anticipate that Alliance Pharma's Revenue will grow at a rate of 34.21%.

2024 Rev Forecast
£0.20B
2025 Rev Forecast
£0.22B
2026 Rev Forecast
£0.22B
2027 Rev Forecast
£0.24B
2028 Rev Forecast
£0.23B
2029 Rev Forecast
£0.22B
2030 Rev Forecast
£0.22B

Alliance Pharma Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, Alliance Pharma's Dividend per Share has fallen from £0.02 to £0.02 – a 0.00% decrease. According to 6 analysts, Alliance Pharma's Dividend per Share will fall by 0.00% in the next year, reaching £0.02. Professionals believe that By 2030, Alliance Pharma's Dividend per Share will fall to £0.02 – a 0.00% decrease from its current value.

2024 DPS Forecast
£0.02
2025 DPS Forecast
£0.02
2026 DPS Forecast
£0.02
2027 DPS Forecast
£0.02
2028 DPS Forecast
£0.02
2029 DPS Forecast
£0.02
2030 DPS Forecast
£0.02

Alliance Pharma Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
£0.03B
2025 FCF Forecast
£0.04B
2026 FCF Forecast
£0.03B
2027 FCF Forecast
£0.03B
2028 FCF Forecast
£0.03B
2029 FCF Forecast
£0.03B
2030 FCF Forecast
£0.03B

Alliance Pharma EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Alliance Pharma's EBITDA has decreased by 3.71%, going from £37.78M to £36.38M. For next year, analysts predict EBITDA of £50.51M, which would mean an increase of 38.84%. Over the next seven years, experts predict that Alliance Pharma's EBITDA will grow at a rate of 46.08%.

2024 EBITDA Forecast
£0.05B
2025 EBITDA Forecast
£0.06B
2026 EBITDA Forecast
£0.06B
2027 EBITDA Forecast
£0.05B
2028 EBITDA Forecast
£0.05B
2029 EBITDA Forecast
£0.05B
2030 EBITDA Forecast
£0.05B

Alliance Pharma EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Alliance Pharma's EBIT has decreased from £29.67M to £28.43M – a 4.18% drop. For next year, analysts predict EBIT of £45.43M, which would mean an increase of 59.80%. Over the next seven years, experts predict that Alliance Pharma's EBIT will grow at a rate of 101.90%.

2024 EBIT Forecast
£0.05B
2025 EBIT Forecast
£0.05B
2026 EBIT Forecast
£0.05B
2027 EBIT Forecast
£0.05B
2028 EBIT Forecast
£0.05B
2029 EBIT Forecast
£0.06B
2030 EBIT Forecast
£0.06B

Alliance Pharma EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Alliance Pharma's EPS has gone down from £0.05 to £0.00 – a 100.00% drop. The next year looks promising for Alliance Pharma, with analysts predicting EPS of £0.05 – an increase of 100.00%. Over the next seven years, experts anticipate that Alliance Pharma's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
£0.05
2025 EPS Forecast
£0.06
2026 EPS Forecast
£0.07
2027 EPS Forecast
£0.08
2028 EPS Forecast
£0.07
2029 EPS Forecast
£0.07
2030 EPS Forecast
£0.07